Zi Hui
Impact in
- Toxicology top 10%
- Bioactive Compounds and Antitumor Agents
-
- Synthesis and biological activity
- Click Chemistry and Applications
Papers in
-
- Histone Deacetylase Inhibitors Research 9
- Protein Degradation and Inhibitors 8
- DNA Repair Mechanisms 4
- Cancer therapeutics and mechanisms 4
- CRISPR and Genetic Engineering 2
- Epigenetics and DNA Methylation 2
-
- Click Chemistry and Applications 3
- Co-authors
- Xiang‐Yang Ye (24 shared papers)Tian Xie (16 shared papers)Renren Bai (8 shared papers)Xingrui He (6 shared papers)Yuan Gao (5 shared papers)Junlong Zhu (2 shared papers)Carmen Rosa Garrido (6 shared papers)Xiaoying Jiang (3 shared papers)
- Journals
- Expert Opinion on Therapeutic Patents (4 papers)Bioorganic Chemistry (4 papers)Molecules (3 papers)European Journal of Medicinal Chemistry (3 papers)Molecular Diversity (2 papers)
- Partner nations
- ChinaFranceUnited States
In The Last Decade
Zi Hui
31 papers receiving 530 citations
Peers
Comparison fields: 5 of 83
- Toxicology 27
- Organic Chemistry 132
- Molecular Biology 285
- Oncology 99
- Pharmacology 19
Countries citing papers authored by Zi Hui
This map shows the geographic impact of Zi Hui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zi Hui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zi Hui more than expected).
Fields of papers citing papers by Zi Hui
This network shows the impact of papers produced by Zi Hui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zi Hui. The network helps show where Zi Hui may publish in the future.
Co-authors
The 25 scholars most cited alongside Zi Hui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 60 | |
| 2 | 2021 | 55 | |
| 3 | 2022 | 55 | |
| 4 | 2024 | 53 | |
| 5 | 2020 | 45 | |
| 6 | 2023 | 35 | |
| 7 | 2020 | 29 | |
| 8 | 2023 | 22 | |
| 9 | 2022 | 17 | |
| 10 | 2022 | 17 | |
| 11 | 2024 | 14 | |
| 12 | 2023 | 14 | |
| 13 | 2014 | 14 | |
| 14 | 2020 | 13 | |
| 15 | 2020 | 12 | |
| 16 | 2016 | 11 | |
| 17 | 2022 | 11 | |
| 18 | 2022 | 10 | |
| 19 | 2023 | 7 | |
| 20 | 2024 | 6 |
About Zi Hui
Zi Hui is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Pharmacology and Cell Biology, having authored 33 papers that have together received 536 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (9 papers), Protein Degradation and Inhibitors (8 papers), DNA Repair Mechanisms (4 papers), Cancer therapeutics and mechanisms (4 papers), PARP inhibition in cancer therapy (3 papers), Click Chemistry and Applications (3 papers), CRISPR and Genetic Engineering (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Toxicology (27 citations), Organic Chemistry (132 citations), Molecular Biology (285 citations), Oncology (99 citations) and Pharmacology (19 citations). Zi Hui has collaborated with scholars based in China, France and United States. Frequent co-authors include Xiang‐Yang Ye, Tian Xie, Renren Bai, Xingrui He, Yuan Gao, Junlong Zhu, Carmen Rosa Garrido, Xiaoying Jiang, Liwei Wang and Frédéric Lirussi. Their work appears in journals such as Expert Opinion on Therapeutic Patents, Bioorganic Chemistry, Molecules, European Journal of Medicinal Chemistry and Molecular Diversity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.